CAREDX, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
CAREDX, INC. (CDNA) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $21.59 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2022-11-03
- 2022-09-30: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month $21.59M.
- 2021-09-30: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month $5.46M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month |
|---|---|
| 2022-09-30 | $21.59M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $5.46M 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |